NASDAQ:RKDAArcadia Biosciences Stock Price, Forecast & News

Arcadia Biosciences' stock was trading at $3.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RKDA stock has increased by 21.5% and is now trading at $3.85. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Arcadia Biosciences.

Arcadia Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Arcadia Biosciences.

Arcadia Biosciences Inc (NASDAQ:RKDA) issued its quarterly earnings results on Wednesday, May, 13th. The basic materials company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of ($0.55) by $0.84. The basic materials company had revenue of $0.31 million for the quarter, compared to analysts' expectations of $0.60 million. Arcadia Biosciences had a negative return on equity of 180.70% and a negative net margin of 1,035.38%. View Arcadia Biosciences' earnings history.

Arcadia Biosciences's stock reverse split before market open on Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 23rd 2018. An investor that had 100 shares of Arcadia Biosciences stock prior to the reverse split would have 5 shares after the split.

2 equities research analysts have issued 1 year price targets for Arcadia Biosciences' stock. Their forecasts range from $14.00 to $16.00. On average, they anticipate Arcadia Biosciences' share price to reach $15.00 in the next year. This suggests a possible upside of 289.6% from the stock's current price. View analysts' price targets for Arcadia Biosciences.

News stories about RKDA stock have been trending negative on Sunday, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Arcadia Biosciences earned a news impact score of -2.2 on InfoTrie's scale. They also assigned press coverage about the basic materials company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the next several days. View the latest news about Arcadia Biosciences.

Some companies that are related to Arcadia Biosciences include CVR Partners (UAN), Wynnstay Group (WYN), Eden Research (EDEN), Evogene (EVGN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT) and ICL Group (ICL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcadia Biosciences investors own include Micron Technology (MU), Corbus Pharmaceuticals (CRBP), NVIDIA (NVDA), Opko Health (OPK), Inovio Pharmaceuticals (INO), Netflix (NFLX), Sorrento Therapeutics (SRNE), Verastem (VSTM), Yield10 Bioscience (YTEN) and Advanced Micro Devices (AMD).

(RKDA) raised $66 million in an initial public offering (IPO) on Friday, May 15th 2015. The company issued 8,200,000 shares at a price of $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.

Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."

Shares of RKDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RKDA stock can currently be purchased for approximately $3.85.

Arcadia Biosciences has a market capitalization of $33.30 million and generates $1.17 million in revenue each year. The basic materials company earns $-28,810,000.00 in net income (profit) each year or ($3.37) on an earnings per share basis. Arcadia Biosciences employs 44 workers across the globe.

The official website for Arcadia Biosciences is www.arcadiabio.com.

Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]